Models
ALKEM LABORATORIES LTD.ALKEMPharmaceuticals & Biotechnology
2,890per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model2,890implied FY26 P/E 16.0× · EV/EBITDA 12.7×
Against CMP ₹5,087.5043.2%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3179%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
2,1914,285
52-week rangetraded range, a fact not a value
5,0755,934

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow7,694
PV of terminal value28,230
Enterprise value35,924
less net debt(1,376)
less non-controlling interest0
add non-operating investments0
Equity value34,548
÷ 11.96 crore shares2,890
79% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.

Free cash flow, filed and modelled · ₹ '000 crore

0112233FY21: ₹1,070 croreFY21FY22: ₹772 croreFY22FY23: ₹1,450 croreFY23FY24: ₹1,689 croreFY24FY25: ₹1,237 croreFY25FY26: ₹1,346 croreFY26FY27: ₹1,458 croreFY27FY28: ₹1,706 croreFY28FY29: ₹1,994 croreFY29FY30: ₹2,329 croreFY30FY31: ₹2,718 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%2,9913,2263,5093,8544,285
10.50%2,7442,9403,1713,4483,787
11.00%2,5332,6982,8903,1173,389
11.50%2,3512,4912,6522,8413,064
12.00%2,1912,3112,4492,6082,793
The outlined cell is your model. Green figures sit above the CMP of ₹5,087.50; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P102,285P502,854P903,561
10th · 50th · 90th percentile, ₹ per share2,285 · 2,854 · 3,561
Draws below the CMP100%
Rank correlation with ebitda margin+0.74
Rank correlation with discount rate0.56
Rank correlation with revenue growth+0.26
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue11,59912,66812,96514,71216,69818,95321,51124,41527,711
growth %9.19.22.313.513.513.513.513.513.5
EBITDA1,5062,1242,5122,8303,2063,6394,1304,6885,321
margin %13.016.819.419.219.219.219.219.219.2
less depreciation(310)(299)(357)(382)(434)(493)(559)(635)(720)
EBIT1,1961,8252,1552,4482,7723,1463,5714,0534,600
less tax on EBIT(441)(499)(566)(643)(730)(828)
NOPAT2,0082,2732,5802,9283,3233,772
add depreciation310299357382434493559635720
less capex(233)(259)(676)(617)(701)(745)(787)(828)(865)
less working-capital build(548)(622)(706)(802)(910)
Free cash flow to firm1,4501,6891,2371,4581,7061,9942,3292,718
Discount factor0.9490.8550.7700.6940.625
Present value1,3841,4581,5361,6161,700
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 1,624, dividends at 26.7% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT2,4482,7723,1463,5714,0534,600
Interest at 12% on debt(195)(195)(195)(195)(195)
Profit before tax2,5772,9513,3763,8584,405
Profit after tax2,3022,1132,4202,7683,1643,612
Dividends(614)(564)(646)(739)(845)(964)
Balance sheet, year end
Cash2489821,8812,9764,3015,895
Working capital4,0674,6155,2375,9446,7457,655
Net block and other assets16,55816,82517,07717,30517,49817,642
Debt1,6241,6241,6241,6241,6241,624
Equity14,34915,89817,67219,70122,02024,668
Balance check00(0)(0)(0)(0)
Cash flow
From operations1,9992,2912,6212,9973,423
Investing (capex)(701)(745)(787)(828)(865)
Financing (dividends)(564)(646)(739)(845)(964)
Net change in cash7349001,0951,3251,594
Free cash flow to equity1,2981,5461,8342,1692,559
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF13.5%19.2%11.00%5%2,890(43.2)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.